ANTI-BLTR Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Suggested starting dilutions are as follows: IHC-P: 1:100-1:1000, WB: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.

Biochem/physiol Actions

Receptor for extracellular ATP > UTP and ADP. The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. May be the cardiac P2Y receptor involved in the regulation of cardiac muscle contraction through modulation of L-type calcium currents. Is a receptor for leukotriene B4, a potent chemoattractant involved in inflammation and immune response.

ANTI-BLTR Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ANTI-BLTR Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Atlas antibodies	--	order@atlasantibodies.com	China	6586	58
Merck KGaA	--	ordercn@merckgroup.com	China	6394	58

---

• Anti-NOP9 antibody produced in rabbit
• Anti-LTB4R antibody produced in rabbit
• Anti-CMKLR1 antibody produced in rabbit
• Anti-C14ORF21 antibody produced in rabbit
• Monoclonal Anti-CMKLR1 antibody produced in rat
• ANTI-BLTR
• ANTI-CHEMERINR
• ANTI-CHEMERIN RECEPTOR
• ANTI-CHEMR23
• ANTI-CHEMOKINE-LIKE RECEPTOR 1
• ANTI-GPR16
• ANTI-G PROTEIN-COUPLED RECEPTOR 16
• ANTI-LTB4R
• ANTI-LEUKOTRIENE B4 G PROTEIN-COUPLED RECEPTOR
• ANTI-LEUKOTRIENE B4 RECEPTOR
• ANTI-P2RY7
• ANTI-PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 7
• ANTI-PURINOCEPTOR P2Y7
• MONOCLONAL ANTI-CMKLR1
• Anti-C14orf21
• Anti-Uncharacterized protein C14orf21
• C14orf21
• Anti-KIAA2021